Showing results (491-500 of 530) with videos related to
Sort By:
Pageof 53
The American Journal of Medicine|July 27, 2013
Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDsDaniel H Solomon, Jeffrey R Curtis, Kenneth G Saag, et al.Seminars in Arthritis and Rheumatism|February 16, 2023
Humoral and cellular immune responses in persons with rheumatoid arthritis after a third dose of mRNA COVID-19 vaccineSara K Tedeschi, Daniel H Solomon, Yuezhou Chen, et al.Pain|June 1, 2019
The contribution of obesity to prescription opioid use in the United StatesAndrew Stokes, Kaitlyn M Berry, Jason M Collins, et al.Journal of the American College of Cardiology|April 21, 2018
Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or IbuprofenGrant W Reed, Mouin S Abdallah, Mingyuan Shao, et al.Seminars in Arthritis and Rheumatism|August 3, 2010
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registriesJeffrey R Curtis, Archana Jain, Johan Askling, et al.Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2017
Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: A Randomized Clinical TrialDaniel H Solomon, M Elaine Husni, Katherine E Wolski, et al.The Journal of Rheumatology|August 1, 2025
Quality of Life in Adult Patients With SAPHO Syndrome and Chronic Nonbacterial Osteomyelitis, and Comparison to Chronic Rheumatic and Inflammatory DiseasesAleksander Lenert, Jenna Thomason, Melanie H Smith, et al.ACR Open Rheumatology|May 1, 2021
Testing the Effects of Disease-Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: Rationale and Design of the TARGET TrialJon T Giles, Pamela M Rist, Katherine P Liao, et al.JAMA|November 8, 2011
Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseasesCarlos G Grijalva, Lang Chen, Elizabeth Delzell, et al.Annals of the Rheumatic Diseases|November 30, 2022
Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritisDaniel H Solomon, Jon T Giles, Katherine P Liao, et al.Pageof 53